Type B3 Thymoma And Thymic Carcinoma clinical trials

Explore recruiting type b3 thymoma and thymic carcinoma clinical trials.

Also recruiting in Europe

Type B3 Thymoma And Thymic Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EORTC-1525-LCG: Single-arm, multicenter, phase II study of immunotherapy in patients with type B3 thymoma and thymic carcinoma previously treated with chemotherapy - (Nivothym)

Belgium, Spain, Netherlands, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Type B3 Thymoma And Thymic Carcinoma trials by city

Type B3 Thymoma And Thymic Carcinoma in Toronto Type B3 Thymoma And Thymic Carcinoma in Vancouver Type B3 Thymoma And Thymic Carcinoma in Montreal Type B3 Thymoma And Thymic Carcinoma in Calgary Type B3 Thymoma And Thymic Carcinoma in Edmonton Type B3 Thymoma And Thymic Carcinoma in Ottawa Type B3 Thymoma And Thymic Carcinoma in Winnipeg Type B3 Thymoma And Thymic Carcinoma in Quebec City Type B3 Thymoma And Thymic Carcinoma in Hamilton Type B3 Thymoma And Thymic Carcinoma in Kitchener Type B3 Thymoma And Thymic Carcinoma in London Type B3 Thymoma And Thymic Carcinoma in Halifax Type B3 Thymoma And Thymic Carcinoma in New York Type B3 Thymoma And Thymic Carcinoma in Los Angeles Type B3 Thymoma And Thymic Carcinoma in Chicago Type B3 Thymoma And Thymic Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease